This announcement is exactly what i stated the other day.
Phase 2 will take at least a year to complete.
Its mid 2013 before there will be any results for ATL1103 and thats only phase 2.
This is so far off in the future that on this announcement alone and the time involved i would expect to see significant weakness and a CR urgently needed in the near future as completing Phase 2 is expensive.
No rush here whatsoever IMO.
All in my opinion and GL.
Cheers
Rob
- Forums
- ASX - By Stock
- PER
- atl1103 development update
PER
percheron therapeutics limited
Add to My Watchlist
5.88%
!
0.8¢

atl1103 development update, page-49
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $8.699M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $2.01K | 251.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4817091 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1969872 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4817091 | 0.008 |
3 | 2142857 | 0.007 |
2 | 1450000 | 0.006 |
2 | 3999997 | 0.005 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1969872 | 4 |
0.010 | 1993383 | 7 |
0.011 | 2542858 | 6 |
0.012 | 2658324 | 5 |
0.013 | 500000 | 2 |
Last trade - 15.47pm 04/07/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online